Skip to main content
. 2020 Dec 21;10(1):e018366. doi: 10.1161/JAHA.120.018366

Table 1.

Baseline Characteristics

Dual Antiplatelet Therapy P Value
3 mo (n=481) 12 mo (n=491)
Age, y 65.1±10.7 65.3±10.3 0.71
Male 347 (72.1) 360 (73.3) 0.68
Diabetes mellitus 194 (40.3) 190 (38.7) 0.60
Hypertension 294 (61.1) 314 (64.0) 0.36
Dyslipidemia 211 (43.9) 218 (44.4) 0.87
Current smoking 121 (25.2) 116 (23.6) 0.58
Previous myocardial infarction 26 (5.4) 25 (5.1) 0.83
Previous coronary artery bypass graft surgery 6 (1.3) 5 (1.0) 0.74
Previous revascularization 58 (12.1) 67 (13.7) 0.46
Chronic renal failure 15 (3.1) 16 (3.3) 0.90
Left ventricular ejection fraction (%) 60.0±10.6 59.8±11.1 0.80
Clinical presentation 0.38
Stable angina 227 (47.2) 229 (46.6)
Unstable angina 126 (26.2) 150 (30.6)
Non–ST‐segment elevation myocardial infarction 86 (17.9) 76 (15.5)
ST‐segment elevation myocardial infarction 42 (8.7) 36 (7.3)
Multiple‐vessel disease 233 (48.4) 233 (47.5) 0.76
Location of lesion treated
Left main 5 (1.0) 8 (1.6) 0.42
Left anterior descending artery 295 (61.3) 295 (60.1) 0.69
Left circumflex 128 (26.6) 129 (26.3) 0.90
Right coronary artery 176 (36.6) 171 (34.8) 0.57
Lesion complexity
Calcified lesion 89 (18.5) 90 (18.3) 0.94
Bifurcation lesion 60 (12.5) 61 (12.4) 0.98
Thrombotic lesion 34 (7.1) 33 (6.7) 0.83
Use of intravascular ultrasound 91 (18.9) 110 (22.4) 0.18
Treated lesions per patient 1.4±0.7 1.3±0.6 0.14
Multilesion intervention 150 (31.2) 143 (29.1) 0.48
Multivessel intervention 114 (23.7) 111 (22.6) 0.69
Number of stents per patient 1.5±0.8 1.4±0.7 0.12
Mean stent diameter per patient, mm 3.0±0.4 3.0±0.4 0.91
Total stent length per patient, mm 38.5±22.8 35.9±21.1 0.07

Data are n (%) or means±SD.